Making Sense of Today’s 340B Policy Entanglements As covered entities face rising healthcare costs, reimbursement cuts, and uncompensated care, the Federal 340B Drug Pricing Program continues to be an important source of funding for vital patient care. Get updates on how the 340B program solutions can help providers manage reporting compliance across an incr ... Show More
Yesterday
More Than Meds: The Mission Behind PRISM | Pharmacist-Prescribed
<p>In this episode of Pharmacist-Prescribed, hosts Mary Kucek and Devin Bustin, MD, explore the mission behind PRISM and the urgent need for pharmacist-led clinical services. They discuss the growing gaps in healthcare access, the underutilization of pharmacists as providers, and ... Show More
44m 30s
Nov 2023
CVS vs. Walgreens | Trouble Behind the Counter | 5
<p>Between overworked pharmacists, healthcare consolidation, and rising drug costs, pharmacies are constantly having to adapt. Dan Weissmann, host of the <a href="https://armandalegshow.com/home/" rel="noopener noreferrer" target="_blank">An Arm and a Leg</a> podcast, joins David ... Show More
42m 21s
Nov 2023
For ACA Plans, It’s Time to Shop Around
<p>It’s Obamacare open enrollment season, which means that, for people who rely on these plans for coverage, it’s time to shop around. With enhanced premium subsidies and cost-sharing assistance, consumers may find savings by switching plans. It is especially important for people ... Show More
28m 46s
Jun 2016
Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ... Show More
6m 38s